Potentiated antitumor activity of poly-γ-glutamic acid combined with anti PD-L1 blockade on murine models of colorectal cancer

被引：0
|
作者：
Jang, Jae-Pyung
Yoo, Chan-Hee
Hahm, Kyung-Soo
Lee, Do Young
Park, Young-Chul
Choi, Jae Chul
机构：
来源：
CANCER RESEARCH | 2024年 / 84卷 / 06期
关键词：
D O I：
10.1158/1538-7445.AM2024-4044
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4044
引用
收藏
页数：2
相关论文
共 50 条
  • [21] PD-L1 blockade in preclinical models of PTEN-deficient prostate cancer
    De Velasco, Marco A.
    Kura, Yurie
    Ando, Naomi
    Sato, Noriko
    Sakai, Kazuko
    Davies, Barry R.
    Sugimoto, Koichi
    Nozawa, Masahiro
    Yoshimura, Kazuhiro
    Yoshikawa, Kazuhiro
    Nishio, Kazuto
    Uemura, Hirotsugu
    CANCER RESEARCH, 2017, 77
  • [22] Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
    Zaslavsky, Alexander B.
    Adams, M. P.
    Cao, X.
    Maj, T.
    Choi, J. E.
    Stangl-Kremser, J.
    Patel, S.
    Putelo, A.
    Lee, S. K.
    Nallandhighal, S.
    Kasputis, A.
    Alva, A.
    Lew, M.
    Qin, A.
    Mehra, R.
    Morgan, T. M.
    Salami, S. S.
    Reichert, Z.
    Udager, A.
    Zou, W.
    Palapattu, Ganesh S.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [23] Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
    Alexander B. Zaslavsky
    M. P. Adams
    X. Cao
    T. Maj
    J. E. Choi
    J. Stangl-Kremser
    S. Patel
    A. Putelo
    S. K. Lee
    S. Nallandhighal
    A. Kasputis
    A. Alva
    M. Lew
    A. Qin
    R. Mehra
    T. M. Morgan
    S. S. Salami
    Z. Reichert
    A. Udager
    W. Zou
    Ganesh S. Palapattu
    Scientific Reports, 10
  • [24] Attenuated Salmonella potentiate PD-L1 blockade immunotherapy in a preclinical model of colorectal cancer
    Al-Saafeen, Besan H.
    Al-Sbiei, Ashraf
    Bashir, Ghada
    Mohamed, Yassir A.
    Masad, Razan J.
    Fernandez-Cabezudo, Maria J.
    al-Ramadi, Basel K.
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [25] A novel combinatorial cancer immunotherapy poly-IC and blockade of the PD-1/PD-L1 pathway
    Nagato, Toshihiro
    Celis, Esteban
    ONCOIMMUNOLOGY, 2014, 3 (05)
  • [26] Combined PD-1 blockade and GITR triggering induce a potent antitumor immunity in murine cancer models and synergizes with chemotherapeutic drugs
    Lei Lu
    Xiaobing Xu
    Bin Zhang
    Rongsheng Zhang
    Hongzan Ji
    Xuan Wang
    Journal of Translational Medicine, 12
  • [27] Combined PD-1 blockade and GITR triggering induce a potent antitumor immunity in murine cancer models and synergizes with chemotherapeutic drugs
    Lu, Lei
    Xu, Xiaobing
    Zhang, Bin
    Zhang, Rongsheng
    Ji, Hongzan
    Wang, Xuan
    JOURNAL OF TRANSLATIONAL MEDICINE, 2014, 12
  • [28] Anti-PD-1/PD-L1 therapy for colorectal cancer: Clinical implications and future considerations
    Chen, Xiang
    Chen, Ling-Juan
    Peng, Xiao-Fei
    Deng, Ling
    Wang, Yan
    Li, Jiu-Jiang
    Guo, Dong-Li
    Niu, Xiao-Hua
    TRANSLATIONAL ONCOLOGY, 2024, 40
  • [29] The role of in vivo PD-1/PD-L1 interactions in syngeneic and allogeneic antitumor responses in murine tumor models.
    Zuberek, K
    Runyon, K
    Collins, M
    Leonard, JP
    Dunussi-Joannopoulos, K
    BLOOD, 2001, 98 (11) : 42B - 42B
  • [30] Cellular mechanisms of combining innate immunity activation with PD-1/PD-L1 blockade in treatment of colorectal cancer
    Xie, Qi
    Liu, Xiaolin
    Liu, Rengyun
    Pan, Jingxuan
    Liang, Jing
    MOLECULAR CANCER, 2024, 23 (01)
12345